Product Code: ETC8853935 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Devices such as laparoscopic instruments, hysteroscopes, and radiofrequency ablation systems are increasingly used in fibroid management. The adoption of these technologies is limited to better-equipped hospitals and specialty clinics, where trained gynecologic surgeons operate.
Minimally invasive and image-guided devices used in treating uterine fibroids are gaining traction in the Philippines, particularly in tertiary hospitals and urban specialty centers. Technologies such as uterine artery embolization (UAE) devices, radiofrequency ablation systems, and MRI-guided focused ultrasound devices are becoming more common, driven by patient demand for less invasive treatment alternatives. Market growth is also supported by the modernization of private hospitals and increasing investments in womens health infrastructure.
This market encounters regulatory delays for approval of new medical devices and limited training for practitioners in device-based interventions. The high cost of equipment such as ultrasound-guided systems and radiofrequency ablation tools also limits hospital adoption, especially outside urban areas.
Advanced treatment options such as MR-guided focused ultrasound and radiofrequency ablation are gaining traction. Investors can introduce these technologies through partnerships with top-tier hospitals or invest in mobile treatment units to improve access in secondary cities.
Devices such as uterine artery embolization tools, laparoscopic systems, and ultrasound-based therapies must be certified by the FDA as Class C or D medical devices. Hospitals using these devices must be accredited and maintain operating room and technician standards regulated by the Health Facilities and Services Regulatory Bureau (HFSRB). The DOH supports device-based fibroid treatment through equipment grants to provincial and regional health centers, as part of the Medical Assistance to Indigent Patients (MAIP) program.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Uterine Fibroid Treatment Device Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Uterine Fibroid Treatment Device Market - Industry Life Cycle |
3.4 Philippines Uterine Fibroid Treatment Device Market - Porter's Five Forces |
3.5 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume Share, By Mode of Treatment, 2021 & 2031F |
4 Philippines Uterine Fibroid Treatment Device Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Uterine Fibroid Treatment Device Market Trends |
6 Philippines Uterine Fibroid Treatment Device Market, By Types |
6.1 Philippines Uterine Fibroid Treatment Device Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume, By Surgical Techniques, 2021- 2031F |
6.1.4 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume, By Laparoscopic Techniques, 2021- 2031F |
6.1.5 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume, By Ablation Techniques, 2021- 2031F |
6.1.6 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume, By Embolization Techniques, 2021- 2031F |
6.2 Philippines Uterine Fibroid Treatment Device Market, By Mode of Treatment |
6.2.1 Overview and Analysis |
6.2.2 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume, By Invasive Treatment, 2021- 2031F |
6.2.3 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume, By Minimally Invasive Treatment, 2021- 2031F |
6.2.4 Philippines Uterine Fibroid Treatment Device Market Revenues & Volume, By Non-invasive Treatment, 2021- 2031F |
7 Philippines Uterine Fibroid Treatment Device Market Import-Export Trade Statistics |
7.1 Philippines Uterine Fibroid Treatment Device Market Export to Major Countries |
7.2 Philippines Uterine Fibroid Treatment Device Market Imports from Major Countries |
8 Philippines Uterine Fibroid Treatment Device Market Key Performance Indicators |
9 Philippines Uterine Fibroid Treatment Device Market - Opportunity Assessment |
9.1 Philippines Uterine Fibroid Treatment Device Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Philippines Uterine Fibroid Treatment Device Market Opportunity Assessment, By Mode of Treatment, 2021 & 2031F |
10 Philippines Uterine Fibroid Treatment Device Market - Competitive Landscape |
10.1 Philippines Uterine Fibroid Treatment Device Market Revenue Share, By Companies, 2024 |
10.2 Philippines Uterine Fibroid Treatment Device Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |